Engineering clinically relevant volumes of vascularized bone.

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Tissue Engineering

Background:

• Vascularization is a critical hurdle for bone tissue engineering, especially for large defects.
• Adequate blood supply is essential for nutrient/waste transport and cell delivery for bone remodeling.
• Current strategies face significant barriers to clinical translation.

Purpose of the Study:

• To review recent progress in engineering vascularized bone.
• To emphasize the clinical feasibility of current and emerging strategies.
• To identify key challenges and future directions in bone vascularization.

Main Methods:

• Review of existing literature on bone tissue engineering and vascularization techniques.
• Analysis of strategies involving cells, growth factors, biomaterials, and surgical approaches.
• Evaluation of clinical translation potential and associated barriers.

Main Results:

• Multiple strategies, including cell-based therapies, growth factor delivery, advanced biomaterials, and pre-vascularization techniques, have been explored.
• Significant progress has been made, but substantial challenges remain for widespread clinical application.
• Clinical feasibility is often limited by vascular integration, host response, and scalability.

Conclusions:

• Despite advancements, achieving robust and functional vascularization in engineered bone remains a complex challenge.
• Further research focusing on clinical feasibility and overcoming translational barriers is essential.
• Successful clinical implementation requires integrated approaches addressing vascular supply and bone regeneration.